top of page
it's where dermatology lives



AD biologic non-responders benefit from extended Tx
Photo by Dwxn via Wikimedia Commons New research reveals that patients with moderate-to-severe atopic dermatitis (AD) who did not...
John Evans
May 161 min read


Secukinumab shows positive effects in HS at 52 weeks
Patients with moderate to severe hidradenitis suppurativa (HS) treated with secukinumab demonstrate sustained efficacy and symptom...
Allan Ryan
Feb 6, 20232 min read


Dupilumab effective in relieving AD symptoms in children aged six months to six years
Children with eczema between the ages of six months and six years benefit from treatment with dupilumab, according to the results of a...
Allan Ryan
Sep 26, 20222 min read
New monoclonal antibody shows efficacy in CLE
An early study of litifilimab, a humanized monoclonal antibody, has indicated it may be effective in the treatment of cutaneous lupus...
Allan Ryan
Aug 22, 20222 min read


Misuse of alcohol affects response to psoriasis treatment
A study in the British Journal of Dermatology appears to show that alcohol misuse can be associated with poor response to systemic...
John Evans
Sep 20, 20211 min read


Two-year data indicates bimekizumab maintains high levels of psoriatic skin clearance
Study results indicate that maintenance doses of bimekizumab (320 mg) every four or eight weeks can maintain high levels of skin...
John Evans
Aug 9, 20211 min read


Herpes zoster more common in patients with psoriasis, with a higher incidence in those on biologics
A retrospective study from the Taiwan National Health Insurance Research Database of 92,374 patients with psoriasis indicates that those...
Allan Ryan
Jul 12, 20211 min read
Biologics for psoriasis patients may delay or stop progress to psoriatic arthritis
New research from Italy indicates that patients with psoriasis who have been treated with biologic therapies may have a lesser risk of...
Allan Ryan
Jun 28, 20211 min read
Featured Posts




bottom of page